These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 27638330)
1. The impact of thalidomide use in birth defects in Brazil. Sales Luiz Vianna F; Kowalski TW; Fraga LR; Sanseverino MT; Schuler-Faccini L Eur J Med Genet; 2017 Jan; 60(1):12-15. PubMed ID: 27638330 [TBL] [Abstract][Full Text] [Related]
2. Thalidomide embryopathy: Follow-up of cases born between 1959 and 2010. Kowalski TW; Sanseverino MT; Schuler-Faccini L; Vianna FS Birth Defects Res A Clin Mol Teratol; 2015 Sep; 103(9):794-803. PubMed ID: 26043318 [TBL] [Abstract][Full Text] [Related]
3. Epidemiological surveillance of birth defects compatible with thalidomide embryopathy in Brazil. Vianna FS; Lopez-Camelo JS; Leite JC; Sanseverino MT; Dutra Mda G; Castilla EE; Schüler-Faccini L PLoS One; 2011; 6(7):e21735. PubMed ID: 21754997 [TBL] [Abstract][Full Text] [Related]
4. Recognition of the phenotype of thalidomide embryopathy in countries endemic for leprosy: new cases and review of the main dysmorphological findings. Vianna FSL; Schüler-Faccini L; Leite JCL; de Sousa SHC; da Costa LMM; Dias MF; Morelo EF; Doriqui MJR; Maximino CM; Sanseverino MTV Clin Dysmorphol; 2013 Apr; 22(2):59-63. PubMed ID: 23448904 [TBL] [Abstract][Full Text] [Related]
5. Genomic and in silico analyses of CRBN gene and thalidomide embryopathy in humans. Vianna FS; Kowalski TW; Tovo-Rodrigues L; Tagliani-Ribeiro A; Godoy BA; Fraga LR; Sanseverino MT; Hutz MH; Schuler-Faccini L Reprod Toxicol; 2016 Dec; 66():99-106. PubMed ID: 27751757 [TBL] [Abstract][Full Text] [Related]
6. The role of ESCO2, SALL4 and TBX5 genes in the susceptibility to thalidomide teratogenesis. Gomes JDA; Kowalski TW; Fraga LR; Macedo GS; Sanseverino MTV; Schuler-Faccini L; Vianna FSL Sci Rep; 2019 Aug; 9(1):11413. PubMed ID: 31388035 [TBL] [Abstract][Full Text] [Related]
7. Angiogenesis-related genes and thalidomide teratogenesis in humans: an approach on genetic variation and review of past in vitro studies. Kowalski TW; Fraga LR; Tovo-Rodrigues L; Sanseverino MTV; Hutz MH; Schuler-Faccini L; Vianna FSL Reprod Toxicol; 2017 Jun; 70():133-140. PubMed ID: 28161597 [TBL] [Abstract][Full Text] [Related]
8. Pharmacoepidemiology and thalidomide embryopathy surveillance in Brazil. Sales Luiz Vianna F; de Oliveira MZ; Sanseverino MT; Morelo EF; de Lyra Rabello Neto D; Lopez-Camelo J; Camey SA; Schuler-Faccini L Reprod Toxicol; 2015 Jun; 53():63-7. PubMed ID: 25828060 [TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil embryopathy: A newly recognized teratogenic syndrome. Perez-Aytes A; Marin-Reina P; Boso V; Ledo A; Carey JC; Vento M Eur J Med Genet; 2017 Jan; 60(1):16-21. PubMed ID: 27639443 [TBL] [Abstract][Full Text] [Related]
10. Thalidomide-induced teratogenesis: history and mechanisms. Vargesson N Birth Defects Res C Embryo Today; 2015 Jun; 105(2):140-56. PubMed ID: 26043938 [TBL] [Abstract][Full Text] [Related]
11. Multicenter investigation of lifestyle-related diseases and visceral disorders in thalidomide embryopathy at around 50 years of age. Shiga T; Shimbo T; Yoshizawa A Birth Defects Res A Clin Mol Teratol; 2015 Sep; 103(9):787-93. PubMed ID: 26033770 [TBL] [Abstract][Full Text] [Related]
12. Human teratogens and genetic phenocopies. Understanding pathogenesis through human genes mutation. Cassina M; Cagnoli GA; Zuccarello D; Di Gianantonio E; Clementi M Eur J Med Genet; 2017 Jan; 60(1):22-31. PubMed ID: 27639441 [TBL] [Abstract][Full Text] [Related]
13. Thalidomide, a current teratogen in South America. Castilla EE; Ashton-Prolla P; Barreda-Mejia E; Brunoni D; Cavalcanti DP; Correa-Neto J; Delgadillo JL; Dutra MG; Felix T; Giraldo A; Juarez N; Lopez-Camelo JS; Nazer J; Orioli IM; Paz JE; Pessoto MA; Pina-Neto JM; Quadrelli R; Rittler M; Rueda S; Saltos M; Sánchez O; Schüler L Teratology; 1996 Dec; 54(6):273-7. PubMed ID: 9098920 [TBL] [Abstract][Full Text] [Related]
14. Thalidomide embryopathy cases in Brazil after 1965. Paumgartten FJ; Chahoud I Reprod Toxicol; 2006 Jul; 22(1):1-2. PubMed ID: 16427249 [No Abstract] [Full Text] [Related]
16. New cases of thalidomide embryopathy in Brazil. Schuler-Faccini L; Soares RC; de Sousa AC; Maximino C; Luna E; Schwartz IV; Waldman C; Castilla EE Birth Defects Res A Clin Mol Teratol; 2007 Sep; 79(9):671-2. PubMed ID: 17676592 [TBL] [Abstract][Full Text] [Related]
17. The return of thalidomide: can birth defects be prevented? Lary JM; Daniel KL; Erickson JD; Roberts HE; Moore CA Drug Saf; 1999 Sep; 21(3):161-9. PubMed ID: 10487395 [TBL] [Abstract][Full Text] [Related]
18. The teratogenic effects of thalidomide on limbs. Vargesson N J Hand Surg Eur Vol; 2019 Jan; 44(1):88-95. PubMed ID: 30335598 [TBL] [Abstract][Full Text] [Related]
19. A new mammalian model system for thalidomide teratogenesis: Monodelphis domestica. Sorensen D; Sackett A; Urban DJ; Maier J; Vargesson N; Sears KE Reprod Toxicol; 2017 Jun; 70():126-132. PubMed ID: 28130151 [TBL] [Abstract][Full Text] [Related]
20. Thalidomide: the tragedy of birth defects and the effective treatment of disease. Kim JH; Scialli AR Toxicol Sci; 2011 Jul; 122(1):1-6. PubMed ID: 21507989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]